Veralto said sales for Q3 2024 (three-month period ended September 27, 2024) rose 4.7% year-over-year to $1,314 million, and net earnings were $219 million ($0.88 per diluted common share).

1. 01

   Veralto said sales for Q3 2024 (three-month period ended September 27, 2024) rose 4.7% year-over-year to $1,314 million, and net earnings were $219 million ($0.88 per diluted common share).

2. 02

   The company said its operating profit margin for Q3 was 23.4% and its non-GAAP adjusted operating profit margin was 24.1%, and non-GAAP adjusted net earnings were $223 million ($0.89 per diluted share).

3. 03

   Veralto disclosed that operating cash flow for Q3 was $224 million and non-GAAP free cash flow was $215 million, down about 8.0% and about 7.5%, respectively, from $243 million and $232 million a year earlier.

4. 04

   The company said it raised its full-year adjusted diluted EPS outlook to $3.44 to $3.48 from its prior range of $3.37 to $3.45, and maintained its free cash flow conversion outlook at 100% to 110%.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.